My biggest issue is that the debt built up recently has been primarily to buy Australian vet clinics which have limited growth potential vs the product / genetic services that have global appeal & huge growth potential. I understand why they did it re Australian market penetration & cross selling of products but the ROE is pretty poor & there would have been far more capital efficient methods of achieving the same outcome (e.g partnerships).
AHX Price at posting:
46.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)